3/30/2024 | 38229090 | USP-1572547_PROPOFOL RELATED COMPOUND B -(30 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 3 | NOS | 2164.52 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1572558_PROPOFOL RELATED COMPOUND C -(25 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 777.43 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1598020_RABEPRAZOLE RELATED COMPOUND A -(25 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 817.07 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1598031_RABEPRAZOLE RELATED COMPOUND B -(15 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 777.46 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1533046_PHENYLEPHRINE RELATED COMPOUND E -(30 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 777.47 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1112423_INDOMETHACIN RELATED COMPOUND B -(25 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 777.46 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1357170_LACOSAMIDE RELATED COMPOUND F -(30 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 750.78 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1366080_LIDOCAINE RELATED COMPOUND H -(50 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 721.51 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1048630_BENAZEPRIL RELATED COMPOUND B -(15 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 2 | NOS | 1517.06 | USA | BANGALORE AIR |
3/30/2024 | 38229090 | USP-1157024_CYCLOPHOSPHAMIDE RELATED COMPOUND B -(25 MG) -(PHARMACEUTICAL REFERENCE STANDARD) | UNITED STATES PHARMACOPEIAL CONVENTION | 1 | NOS | 777.43 | USA | BANGALORE AIR |